维普期刊资源整合服务平台（V6.5）

62篇 您的检索式：作者名="Bonderman D"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Active endothelin is an important vasoconstrictor in acute coronary thrombi 显示文摘	Adlbrecht C Bonderman D Plass C	2007	Thrombo- sis and Haemostasis2007，97，4：	1
2	Risk factors for chronic thromboembolic pulmonary hypertension显示文摘	Bonderman D Wilkens H Wakounig S		0，，02：	1
3	Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque显示文摘	Bonderman D Teml A Jakowitsch J	2002	Blood2002，99，：	1
4	Predictors of outcome in chron-ic thromboembolic pulmonary hypertension显示文摘	Bonderman D Skoro Sajer N	2007	Circulation2007，115，：	1
5	Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension显示文摘	Bonderman D Nowotny R Skoro-Sajer N		0，，：	1
6	Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT):rationale and design显示文摘	Ghio S Bonderman D Felix SB	2012	Eur J Heart Fail2012，14，8：	1
7	Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque 显示文摘	Bonderman D Teml A Jakowitsch J	2002	Blood2002，99，8：	1
8	Atrial septal defect repair after a 10-month treat- ment with bosentan in a patient with severe pulmonary arte- rial hypertension: a ease report 显示文摘	HOETZENECKER K ANKERSMIT H J BONDERMAN D	2009	J Thorae Cardiovase Snrg2009，137，3：	1
9	Coronary no-reflow iscaused by shedding of active tissue factor from dissectedatherosclerotic plaque显示文摘	Bonderman D Teml A Jakowitsch J	2002	Blood2002，99，8：	1
10	Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension:a current understanding显示文摘	Lang IM Pesavento R Bonderman D	2013	Eur Respir J2013，41，2：	1
11	Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure(DILATE-1):A randomized,Double-Blind,Placebo-Controlled,Single-Dose Study显示文摘	Bonderman D Pretsch I Steringer-Mascherbauer R	2014	Chest2014，，5：	1
12	High prevalence of elevated clotting factor Ⅷ in chronic thromboembotic pulmonary hypertension 显示文摘	Bonderman D Turecek PL Jakowitsch J	2003	Thromb Haemost2003，90，：	1
13	Pulmonary hypertension due to left heart disease: recommendations of the Cologne Consensus Conference 2010显示文摘	Rosenkranz S Bonderman D Buerke M	2010	Dtsch Med Wochenschr2010，135，3：	1
14	Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor显示文摘	Rauch U Bonderman D Bohrmann B	2000	Blood2000，96，1：	1
15	Medical conditions increasing the risk of chronic thromboembolic pulmonary hyperlension 显示文摘	Bonderman D Jakowitsch J Adlbrecht C	2005	Thromb Haemost2005，93，：	1
16	Active endo-thelin is an important vasoconstrictor in acute coronary thrombi显示文摘	Adlbrecht C Bonderman D Plass C	2007	Thromb Haemost2007，97，4：	1
17	Predictors of outcome in chronic thromboembolic pulmonary hypertension 显示文摘	Bonderman D Skoro-Sajer N Jakowitsch J	2007	Circulation2007，115，16：	1
18	Pulmonary hypertension due to left heart disease : updated Recommendations of the Cologne Consensus Conference 2011 显示文摘	Rosenkranz S Bonderman D Buerke M	2011	Int J Cardiol2011，154，1：	1
19	Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor显示文摘	Rauch U Bonderman D Bohrmann B	2000	Blood2000，96，1：	1
20	Riociguat for patients w ith pulmonary hypertension caused by systolic left ventricular dysfunction:a phase IIb double-blind,randomized,placebocontrolled,dose-ranging hemodynamic study显示文摘	Bonderman D Ghio S Felix SB	2013	Circulation2013，128，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示